Lineage Cell Therapeutics, Inc. (LCTX)
AMEX
$1.10-5.17%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 1,673,556
- 52-week high
- —
- 52-week low
- —
- Open
- $1.15
- Day high
- $1.17
- Day low
- $1.09
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $14.56M | -$63.53M | -$0.28 |
| 2024 | $9.5M | -$18.61M | -$0.09 |
| 2023 | $8.95M | -$21.49M | -$0.12 |
| 2022 | $14.7M | -$7.09M | -$0.04 |
| 2021 | $4.34M | -$1.42M | -$0.01 |
About Lineage Cell Therapeutics, Inc.
A company overview for Lineage Cell Therapeutics, Inc. is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is Lineage Cell Therapeutics, Inc.'s stock price today?
- LCTX is trading at $1.10 as of Jul 20, 2026.
- Does Lineage Cell Therapeutics, Inc. pay a dividend?
- Lineage Cell Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.